Tag:

AltheRx

Latest Headlines

Fledging biotech AltheRx nabs Ph3 urology program from GSK

March 25, 2011

Few fledgling biotech companies launch right at the threshold of a Phase III trial. But armed with some unique insights into GlaxoSmithKline's old urology pipeline--slated for termination under the

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Food Development Scientist Job
Yoh - Park Ridge, NJ, USA
Scientist II Job
Yoh - Niskayuna, NY, USA
Senior Manager, Clinical Data Management
TESARO - Waltham, MA
Senior Manager, API Development
TESARO - Waltham, MA
Pilot Manufacturing Scientist Job
Yoh - Cambridge, MA, USA

AltheRx

Latest Headlines

Latest Headlines

Fledging biotech AltheRx nabs Ph3 urology program from GSK

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

AltheRx

Latest Headlines

Latest Headlines

Fledging biotech AltheRx nabs Ph3 urology program from GSK

Related Tags

AltheRx Press Releases

Join 100,000+ Insiders SIGN UP FOR OUR NEWSLETTER

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance